The PDE10A inhibitor, papaverine, differentially activates ERK in male and female rat striatal slices

Neuropharmacology

Volumn 61, Issue 8, 2011, Pages 1275-1281

  Hsu, Yu Tien ^a   Liao, Guanghong ^b   Bi, Xiaoning ^b   Oka, Tetsushi ^c   Tamura, Shigeki ^c   Baudry, Michel ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^b Western University of Health Sciences   (United States)

^c DAIICHI SANKYO CO   (Japan)

Author keywords

Dopamine; ERK; Estrogen; Gender; PDE10A; Striatum

Indexed keywords

2,3,4,5 TETRAHYDRO 7,8 DIHYDROXY 1 PHENYL 1H 3 BENZAZEPINE; 8 CHLORO 2,3,4,5 TETRAHYDRO 3 METHYL 5 PHENYL 1H 3 BENZAZEPIN 7 OL HYDROGEN MALEATE; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; DOPAMINE; DOPAMINE 1 RECEPTOR; DOPAMINE 2 RECEPTOR; MAMMALIAN TARGET OF RAPAMYCIN; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; PAPAVERINE; PHOSPHODIESTERASE; PHOSPHODIESTERASE 10A; QUINPIROLE; SULPIRIDE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CORPUS STRIATUM; DOPAMINERGIC TRANSMISSION; FEMALE; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; RAT; SEX DIFFERENCE; SYNAPTOSOME;

2,3,4,5-TETRAHYDRO-7,8-DIHYDROXY-1-PHENYL-1H-3-BENZAZEPINE; ANALYSIS OF VARIANCE; ANIMALS; CORPUS STRIATUM; DOPAMINE AGONISTS; DOPAMINE ANTAGONISTS; ESTROGENS; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; FEMALE; MALE; MAP KINASE SIGNALING SYSTEM; OVARIECTOMY; PAPAVERINE; PHOSPHODIESTERASE INHIBITORS; PHOSPHORYLATION; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, DOPAMINE D1; RECEPTORS, DOPAMINE D2; SEX CHARACTERISTICS; SULPIRIDE;

EID: 80053589751     PISSN: 00283908     EISSN: 18737064     Source Type: Journal    
DOI: 10.1016/j.neuropharm.2011.07.030     Document Type: Article

References (57)

1. T.J. Bazzett, and J.B. Becker Sex differences in the rapid and acute effects of estrogen on striatal D2 dopamine receptor binding Brain Res. 637 1994 163 172 (Pubitemid 24061044)
2. J.B. Becker, and M.E. Beer The influence of estrogen on nigrostriatal dopamine activity: behavioral and neurochemical evidence for both pre- and postsynaptic components Behav. Brain Res. 19 1986 27 33 (Pubitemid 16168022)
3. J.B. Becker Direct effect of 17 beta-estradiol on striatum: sex differences in dopamine release Synapse 5 1990 157 164 (Pubitemid 20095108)
4. J. Bertran-Gonzalez, C. Bosch, M. Maroteaux, M. Matamales, D. Herve, E. Valjent, and J.A. Girault Opposing patterns of signaling activation in dopamine D1 and D2 receptor-expressing striatal neurons in response to cocaine and haloperidol J. Neurosci. 28 2008 5671 5685
5. J. Bertran-Gonzalez, K. Hakansson, A. Borgkvist, T. Irinopoulou, K. Brami-Cherrier, A. Usiello, P. Greengard, D. Herve, J.A. Girault, E. Valjent, and G. Fisone Histone H3 phosphorylation is under the opposite tonic control of dopamine D2 and adenosine A2A receptors in striatopallidal neurons Neuropsychopharmacology 34 2009 1710 1720
6. F. Bogetto, S. Venturello, U. Albert, G. Maina, and L. Ravizza Gender-related clinical differences in obsessive-compulsive disorder Eur. Psychiatry 14 1999 434 441 (Pubitemid 30022386)
7. M.E. Carroll, and J.J. Anker Sex differences and ovarian hormones in animal models of drug dependence Horm. Behav. 58 2010 44 56
8. S.A. Castner, L. Xiao, and J.B. Becker Sex differences in striatal dopamine: in vivo microdialysis and behavioral studies Brain Res. 610 1993 127 134 (Pubitemid 23144432)
9. J. Chen, M. Rusnak, P.J. Lombroso, and A. Sidhu Dopamine promotes striatal neuronal apoptotic death via ERK signaling cascades Eur. J. Neurosci. 29 2009 287 306
10. T.M. Coskran, D. Morton, F.S. Menniti, W.O. Adamowicz, R.J. Kleiman, A.M. Ryan, C.A. Strick, C.J. Schmidt, and D.T. Stephenson Immunohistochemical localization of phosphodiesterase 10A in multiple mammalian species J. Histochem. Cytochem. 54 2006 1205 1213 (Pubitemid 44623341)
11. G.C. Cotzias, S.T. Miller, L.C. Tang, and P.S. Papavasiliou Levodopa, fertility, and longevity Science 196 1977 549 551 (Pubitemid 8090475)
12. P.W. Czoty, N.V. Riddick, H.D. Gage, M. Sandridge, S.H. Nader, S. Garg, M. Bounds, P.K. Garg, and M.A. Nader Effect of menstrual cycle phase on dopamine D2 receptor availability in female cynomolgus monkeys Neuropsychopharmacology 34 2009 548 554
13. J.M. Daniel, J.K. Sulzer, and J.L. Hulst Estrogen increases the sensitivity of ovariectomized rats to the disruptive effects produced by antagonism of D2 but not D1 dopamine receptors during performance of a response learning task Horm. Behav. 49 2006 38 44 (Pubitemid 41821869)
14. T. Di Paolo Modulation of brain dopamine transmission by sex steroids Rev. Neurosci. 5 1994 27 41 (Pubitemid 24134520)
15. S.M. Evans, and R.W. Foltin Does the response to cocaine differ as a function of sex or hormonal status in human and non-human primates? Horm. Behav. 58 2010 13 21
16. G. Fink, B.E. Sumner, R. Rosie, O. Grace, and J.P. Quinn Estrogen control of central neurotransmission: effect on mood, mental state, and memory Cell Mol. Neurobiol. 16 1996 325 344 (Pubitemid 26231262)
17. C. Fiorentini, F. Gardoni, P. Spano, M. Di Luca, and C. Missale Regulation of dopamine D1 receptor trafficking and desensitization by oligomerization with glutamate N-methyl-d-aspartate receptors J. Biol. Chem. 278 2003 20196 20202 (Pubitemid 36799216)
18. G. Gardos, J.O. Cole, and C. Sniffin An evaluation of papaverine in tardive dyskinesia J. Clin. Pharmacol. 16 1976 304 310
19. G. Gardos, R.P. Granacher, J.O. Cole, and C. Sniffin The effects of papaverine in tardive dyskinesia Prog. Neuropsychopharmacol. 3 1979 543 550 (Pubitemid 10139945)
20. C. Giampa, D. Laurenti, S. Anzilotti, G. Bernardi, F.S. Menniti, and F.R. Fusco Inhibition of the striatal specific phosphodiesterase PDE10A ameliorates striatal and cortical pathology in R6/2 mouse model of Huntington's disease PLoS One 5 2010 e13417
21. A.L. Hebb, and H.A. Robertson Role of phosphodiesterases in neurological and psychiatric disease Curr. Opin. Pharmacol. 7 2007 86 92 (Pubitemid 46242039)
22. D.R. Heitmiller, P.C. Nopoulos, and N.C. Andreasen Changes in caudate volume after exposure to atypical neuroleptics in patients with schizophrenia may be sex-dependent Schizophr Res. 66 2004 137 142 (Pubitemid 38041111)
23. R.J. Kleiman, L.H. Kimmel, S.E. Bove, T.A. Lanz, J.F. Harms, A. Romegialli, K.S. Miller, A. Willis, S. des Etages, M. Kuhn, and C.J. Schmidt Chronic suppression of phosphodiesterase 10A alters striatal expression of genes responsible for neurotransmitter synthesis, neurotransmission, and signaling pathways implicated in Huntington's disease J. Pharmacol. Exp. Ther. 336 2011 64 76
24. J. Kotera, T. Sasaki, T. Kobayashi, K. Fujishige, Y. Yamashita, and K. Omori Subcellular localization of cyclic nucleotide phosphodiesterase type 10A variants, and alteration of the localization by cAMP-dependent protein kinase-dependent phosphorylation J. Biol. Chem. 279 2004 4366 4375 (Pubitemid 38199025)
25. M. Landry, D. Levesque, and T. Di Paolo Estrogenic properties of raloxifene, but not tamoxifen, on D2 and D3 dopamine receptors in the rat forebrain Neuroendocrinology 76 2002 214 222 (Pubitemid 36151491)
26. M. Le Saux, M. Morissette, and T. Di Paolo ER beta mediates the estradiol increase of D2 receptors in rat striatum and nucleus accumbens Neuropharmacology 50 2006 451 457 (Pubitemid 43209041)
27. A.I. Levey, S.M. Hersch, D.B. Rye, R.K. Sunahara, H.B. Niznik, C.A. Kitt, D.L. Price, R. Maggio, M.R. Brann, and B.J. Ciliax Localization of D1 and D2 dopamine receptors in brain with subtype-specific antibodies Proc. Natl. Acad. Sci. U S A 90 1993 8861 8865 (Pubitemid 23306410)
28. F.S. Menniti, W.S. Faraci, and C.J. Schmidt Phosphodiesterases in the CNS: targets for drug development Nat. Rev. Drug Discov. 5 2006 660 670 (Pubitemid 44151604)
29. A. Nishi, M. Kuroiwa, D.B. Miller, J.P. O'Callaghan, H.S. Bateup, T. Shuto, N. Sotogaku, T. Fukuda, N. Heintz, P. Greengard, and G.L. Snyder Distinct roles of PDE4 and PDE10A in the regulation of cAMP/PKA signaling in the striatum J. Neurosci. 28 2008 10460 10471
30. S.K. Park, M.D. Nguyen, A. Fischer, M.P. Luke, B. Affar el, P.B. Dieffenbach, H.C. Tseng, Y. Shi, and L.H. Tsai Par-4 links dopamine signaling and depression Cell 122 2005 275 287 (Pubitemid 41032990)
31. A. Pazos, M.E. Stoeckel, C. Hindelang, and J.M. Palacios Autoradiographic studies on dopamine D2 receptors in rat pituitary: influence of hormonal states Neurosci. Lett. 59 1985 1 7 (Pubitemid 15017341)
32. L. Pozzi, K. Hakansson, A. Usiello, A. Borgkvist, M. Lindskog, P. Greengard, and G. Fisone Opposite regulation by typical and atypical anti-psychotics of ERK1/2, CREB and Elk-1 phosphorylation in mouse dorsal striatum J. Neurochem. 86 2003 451 459 (Pubitemid 36842444)
33. M.L. Rao, and H. Kolsch Effects of estrogen on brain development and neuroprotection-implications for negative symptoms in schizophrenia Psychoneuroendocrinology 28 Suppl. 2 2003 83 96 (Pubitemid 36332231)
34. H. Sano, Y. Nagai, T. Miyakawa, R. Shigemoto, and M. Yokoi Increased social interaction in mice deficient of the striatal medium spiny neuron-specific phosphodiesterase 10A2 J. Neurochem. 105 2008 546 556 (Pubitemid 351490018)
35. C.J. Schmidt, D.S. Chapin, J. Cianfrogna, M.L. Corman, M. Hajos, J.F. Harms, W.E. Hoffman, L.A. Lebel, S.A. McCarthy, F.R. Nelson, C. Proulx-LaFrance, M.J. Majchrzak, A.D. Ramirez, K. Schmidt, P.A. Seymour, J.A. Siuciak, F.D. Tingley 3rd, R.D. Williams, P.R. Verhoest, and F.S. Menniti Preclinical characterization of selective phosphodiesterase 10A inhibitors: a new therapeutic approach to the treatment of schizophrenia J. Pharmacol. Exp. Ther. 325 2008 681 690 (Pubitemid 351574819)
36. L. Scott, M.S. Kruse, H. Forssberg, H. Brismar, P. Greengard, and A. Aperia Selective up-regulation of dopamine D1 receptors in dendritic spines by NMDA receptor activation Proc. Natl. Acad. Sci. U S A 99 2002 1661 1664 (Pubitemid 34136549)
37. T.F. Seeger, B. Bartlett, T.M. Coskran, J.S. Culp, L.C. James, D.L. Krull, J. Lanfear, A.M. Ryan, C.J. Schmidt, C.A. Strick, A.H. Varghese, R.D. Williams, P.G. Wylie, and F.S. Menniti Immunohistochemical localization of PDE10A in the rat brain Brain Res. 985 2003 113 126 (Pubitemid 37088176)
38. L.M. Shulman Gender differences in Parkinson's disease Gend. Med. 4 2007 8 18 (Pubitemid 46917063)
39. J.A. Siuciak, D.S. Chapin, J.F. Harms, L.A. Lebel, S.A. McCarthy, L. Chambers, A. Shrikhande, S. Wong, F.S. Menniti, and C.J. Schmidt Inhibition of the striatum-enriched phosphodiesterase PDE10A: a novel approach to the treatment of psychosis Neuropharmacology 51 2006 386 396 (Pubitemid 44061894)
40. J.A. Siuciak, S.A. McCarthy, D.S. Chapin, R.A. Fujiwara, L.C. James, R.D. Williams, J.L. Stock, J.D. McNeish, C.A. Strick, F.S. Menniti, and C.J. Schmidt Genetic deletion of the striatum-enriched phosphodiesterase PDE10A: evidence for altered striatal function Neuropharmacology 51 2006 374 385 (Pubitemid 44061880)
41. J.A. Siuciak The role of phosphodiesterases in schizophrenia: therapeutic implications CNS Drugs 22 2008 983 993
42. J.C. Stoof, and J.W. Kebabian Opposing roles for D-1 and D-2 dopamine receptors in efflux of cyclic AMP from rat neostriatum Nature 294 1981 366 368 (Pubitemid 12202858)
43. D.J. Surmeier, J. Ding, M. Day, Z. Wang, and W. Shen D1 and D2 dopamine-receptor modulation of striatal glutamatergic signaling in striatal medium spiny neurons Trends Neurosci. 30 2007 228 235 (Pubitemid 46654239)
44. Y. Takeuchi, and K. Fukunaga Dopamine D2 receptor activates extracellular signal-regulated kinase through the specific region in the third cytoplasmic loop J. Neurochem. 89 2004 1498 1507 (Pubitemid 38802671)
45. 2+/calmodulin-dependent protein kinase II pathways J. Neurochem. 83 2002 784 796 (Pubitemid 35316028)
46. A. Tamir, J. Whittier, and C. Korenyi Huntington's chorea: a sex difference in psychopathological symptoms Dis. Nerv Syst. 30 1969 103
47. L.C. Tang The modulation of dopamine-sensitive adenylate cyclase activity in the mouse caudate nucleus by estradiol Brain Res. 405 1987 178 182 (Pubitemid 17034948)
48. T.L. Thompson, and M.E. Certain Estrogen mediated inhibition of dopamine transport in the striatum: regulation by G alpha i/o Eur. J. Pharmacol. 511 2005 121 126 (Pubitemid 40417717)
49. T.L. Thompson, and R.L. Moss Estrogen regulation of dopamine release in the nucleus accumbens: genomic- and nongenomic-mediated effects J. Neurochem. 62 1994 1750 1756 (Pubitemid 24121865)
50. T.L. Thompson, C.C. Moore, and B. Smith Estrogen priming modulates autoreceptor-mediated potentiation of dopamine uptake Eur. J. Pharmacol. 401 2000 357 363 (Pubitemid 30608720)
51. T.L. Thompson Attenuation of dopamine uptake in vivo following priming with estradiol benzoate Brain Res. 834 1999 164 167 (Pubitemid 29332024)
52. S. Threlfell, S. Sammut, F.S. Menniti, C.J. Schmidt, and A.R. West Inhibition of phosphodiesterase 10A increases the responsiveness of striatal projection neurons to cortical stimulation J. Pharmacol. Exp. Ther. 328 2009 785 795
53. G.F. Wooten, L.J. Currie, V.E. Bovbjerg, J.K. Lee, and J. Patrie Are men at greater risk for Parkinson's disease than women? J. Neurol. Neurosurg. Psychiatry 75 2004 637 639 (Pubitemid 38406668)
54. L. Xiao, and J.B. Becker Effects of estrogen agonists on amphetamine-stimulated striatal dopamine release Synapse 29 1998 379 391 (Pubitemid 28328682)
55. Z. Xie, W.O. Adamowicz, W.D. Eldred, A.B. Jakowski, R.J. Kleiman, D.G. Morton, D.T. Stephenson, C.A. Strick, R.D. Williams, and F.S. Menniti Cellular and subcellular localization of PDE10A, a striatum-enriched phosphodiesterase Neuroscience 139 2006 597 607
56. H.T. Zhang Phosphodiesterase targets for cognitive dysfunction and schizophrenia - a New York academy of sciences meeting IDrugs 13 2010 166 168
57. W. Zhou, K.A. Cunningham, and M.L. Thomas Estrogen regulation of gene expression in the brain: a possible mechanism altering the response to psychostimulants in female rats Brain Res. Mol. Brain Res. 100 2002 75 83 (Pubitemid 34465580)